Moreover, BRCA1 and RAD17 transcripts are reduced specifically in TP53 mutation-carrying tumors from head and neck squamous cell carcinoma (HNSCC) patients. This evidence concerns the gene BRCA1 and head and neck squamous cell carcinoma.